These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1620660)

  • 41. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro.
    Xu MY; Yang DX; Wang SZ; Jin HB; Zou XH; Yang XP; Han JS
    Sheng Li Xue Bao; 1998 Aug; 50(4):469-73. PubMed ID: 11324560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
    Sakatani N; Inui A; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of CCK-receptor antagonists on CCK-stimulated pepsinogen secretion and calcium increase in isolated guinea pig gastric chief cells.
    Sakamoto C; Matozaki T; Nishisaki H; Konda Y; Nagao M; Nakano O
    Dig Dis Sci; 1990 Jul; 35(7):873-8. PubMed ID: 2364841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
    Staley J; Jensen RT; Moody TW
    Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyloroplasty does not disrupt liquid phase gastric emptying or CCK-induced satiety.
    Conover KL; Collins SM; Weingarten HP
    Physiol Behav; 1989 Mar; 45(3):523-8. PubMed ID: 2756044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
    Wu CL; Doong ML; Wang PS
    Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
    Schick RR; Yaksh TL; Go VL
    Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
    Green T; Dimaline R; Peikin S; Dockray GJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-activity relationship of subtypes of cholecystokinin receptors in the cat lower esophageal sphincter.
    Rattan S; Goyal RK
    Gastroenterology; 1986 Jan; 90(1):94-102. PubMed ID: 2998919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites.
    Gaudreau P; Lavigne GJ; Quirion R
    Neuropeptides; 1990 May; 16(1):51-5. PubMed ID: 2174522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats.
    Weatherford SC; Laughton WB; Salabarria J; Danho W; Tilley JW; Netterville LA; Schwartz GJ; Moran TH
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R244-9. PubMed ID: 8447480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
    Karlsson S; Ahrén B
    Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.